Topics

New BioIVT research on botanical-drug interactions published in Applied In Vitro Toxicology

20:00 EDT 1 May 2019 | AAAS

(Rana Healthcare Solutions LLC) This study investigates the potential for clinically-relevant botanical-drug interactions (BDIs) with Boswellia serrata (Indian Frankincense), a botanical that is used as an anti-inflammatory supplement. The popularity of products containing B. serrata extract is growing. US retail sales of B. serrata reached $14.6 million in 2017 and it continues to move up the top 40 list of best-selling herbal supplements; it is currently ranked number 19.

Original Article: New BioIVT research on botanical-drug interactions published in Applied In Vitro Toxicology

NEXT ARTICLE

More From BioPortfolio on "New BioIVT research on botanical-drug interactions published in Applied In Vitro Toxicology"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...